Saxenda
Every GLP-1 the FDA has approved, and the active ingredient inside each one.
What is Saxenda?
Liraglutide 3.0 mg, injected daily rather than weekly, approved for weight management in 2014.
Its half-life is about 13 hours, which is the entire reason for daily dosing. Largely superseded commercially, and priced accordingly.
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Saxenda comes up on this site
On GLP Watchdog, Saxenda comes up in 2 research articles, 8 seller reviews and 4 tools.
Research that discusses it
Drug pages
Tools that use it
Seller reviews that mention it
Other terms under Drugs and brands
Where the evidence lives
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers